X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2025-02-20 | HYPR | Hyperfine, Inc. | Teisseyre Thomas | COO | S - Sale | $1.08 | -3,238 | 84,989 | -4% | -$3,497 | |||||
| DM | 2025-02-14 | ELMD | Electromed, Inc. | Skarvan Kathleen | Dir | S - Sale+OE | $30.48 | -76,583 | 32,622 | -70% | -$2,334,281 | |||||
2025-02-18 | OM | Outset Medical, Inc. | Trigg Leslie | Chair, CEO | S - Sale | $0.90 | -14,611 | 889,739 | -2% | -$13,150 | ||||||
2025-02-18 | OM | Outset Medical, Inc. | Nash Marc | SVP Operations, R, D | S - Sale | $0.90 | -4,204 | 200,764 | -2% | -$3,784 | ||||||
2025-02-18 | OM | Outset Medical, Inc. | Brottem John L. | GC | S - Sale | $0.90 | -6,145 | 175,043 | -3% | -$5,531 | ||||||
2025-02-18 | OM | Outset Medical, Inc. | Ahmed Nabeel | CFO | S - Sale | $0.90 | -8,659 | 250,210 | -3% | -$7,793 | ||||||
2025-02-18 | HYPR | Hyperfine, Inc. | Teisseyre Thomas | COO | S - Sale | $1.20 | -3,237 | 84,990 | -4% | -$3,884 | ||||||
2025-02-12 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $26.54 | -92 | 262,623 | 0% | -$2,442 | ||||||
2025-02-12 | BLFS | Biolife Solutions Inc | Wichterman Troy | CFO | S - Sale | $26.54 | -159 | 121,620 | 0% | -$4,220 | ||||||
2025-02-12 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $26.54 | -78 | 156,567 | 0% | -$2,070 | ||||||
2025-02-12 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $26.54 | -102 | 106,962 | 0% | -$2,707 | ||||||
2025-02-12 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $26.54 | -53 | 60,191 | 0% | -$1,407 | ||||||
2025-02-11 | CNMD | Conmed Corp | Glaze Richard | CIO | S - Sale | $65.35 | -257 | 0 | -100% | -$16,796 | ||||||
2025-02-04 | NXL | Nexalin Technology, Inc. | Owens David | Chief Medical Officer | P - Purchase | $3.10 | +1,000 | 155,793 | +1% | +$3,100 | ||||||
2025-02-04 | NXL | Nexalin Technology, Inc. | Owens David | Chief Medical Officer | P - Purchase | $2.98 | +1,000 | 154,793 | +1% | +$2,980 | ||||||
2025-02-03 | ZYXI | Zynex Inc | Moorhead Daniel J | CFO | S - Sale | $7.68 | -10,000 | 19,738 | -34% | -$76,800 | ||||||
2025-01-28 | NXL | Nexalin Technology, Inc. | Owens David | Chief Medical Officer | P - Purchase | $2.70 | +1,500 | 153,793 | +1% | +$4,050 | ||||||
| D | 2025-01-24 | MDT | Medtronic Plc | Wall Brett A. | EVP, Pres Neuroscience | S - Sale+OE | $90.00 | -12,437 | 40,979 | -23% | -$1,119,330 | |||||
| M | 2025-01-13 | NXL | Nexalin Technology, Inc. | Owens David | Chief Medical Officer | P - Purchase | $2.57 | +3,000 | 152,293 | +2% | +$7,700 | |||||
2025-01-21 | OM | Outset Medical, Inc. | Trigg Leslie | Chair, CEO | S - Sale | $0.80 | -65,236 | 904,350 | -7% | -$52,189 | ||||||
2025-01-21 | OM | Outset Medical, Inc. | Nash Marc | SVP Operations, R, D | S - Sale | $0.80 | -23,221 | 204,968 | -10% | -$18,577 | ||||||
2025-01-21 | OM | Outset Medical, Inc. | Brottem John L. | GC | S - Sale | $0.80 | -32,930 | 181,188 | -15% | -$26,344 | ||||||
2025-01-21 | OM | Outset Medical, Inc. | Ahmed Nabeel | CFO | S - Sale | $0.80 | -34,288 | 258,869 | -12% | -$27,430 | ||||||
2025-01-13 | OM | Outset Medical, Inc. | Trigg Leslie | Chair, CEO | S - Sale | $0.81 | -33,227 | 870,167 | -4% | -$26,914 | ||||||
2025-01-13 | OM | Outset Medical, Inc. | Nash Marc | SVP Operations, R, D | S - Sale | $0.81 | -15,011 | 222,291 | -6% | -$12,159 | ||||||
2025-01-13 | OM | Outset Medical, Inc. | Brottem John L. | GC | S - Sale | $0.81 | -20,492 | 205,028 | -9% | -$16,599 | ||||||
2025-01-13 | OM | Outset Medical, Inc. | Ahmed Nabeel | CFO | S - Sale | $0.81 | -29,031 | 279,901 | -9% | -$23,515 | ||||||
| D | 2025-01-08 | MDT | Medtronic Plc | Wall Brett A. | EVP, Pres Neuroscience | S - Sale+OE | $80.41 | -9,850 | 40,708 | -19% | -$792,039 | |||||
| D | 2025-01-07 | TMDX | Transmedics Group, Inc. | Khayal Tamer I | Chief Commercial Officer | S - Sale+OE | $80.05 | -1,083 | 20,843 | -5% | -$86,694 | |||||
2025-01-06 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $27.02 | -240 | 60,244 | 0% | -$6,485 | ||||||
2025-01-06 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $27.02 | -404 | 262,715 | 0% | -$10,916 | ||||||
2025-01-06 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $27.02 | -343 | 107,064 | 0% | -$9,268 | ||||||
2024-10-31 | BLFS | Biolife Solutions Inc | De Greef Roderick | Pres, CEO | S - Sale | $23.43 | -46,896 | 414,958 | -10% | -$1,098,773 | ||||||
2025-01-06 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $27.02 | -328 | 156,645 | 0% | -$8,863 | ||||||
2025-01-06 | BLFS | Biolife Solutions Inc | Wichterman Troy | CFO | S - Sale | $27.02 | -987 | 121,779 | -1% | -$26,669 | ||||||
2025-01-07 | OM | Outset Medical, Inc. | Trigg Leslie | Chair, CEO | S - Sale | $1.29 | -10,227 | 903,394 | -1% | -$13,193 | ||||||
2025-01-07 | OM | Outset Medical, Inc. | Nash Marc | SVP Operations, R, D | S - Sale | $1.29 | -720 | 237,302 | 0% | -$929 | ||||||
2025-01-07 | OM | Outset Medical, Inc. | Brottem John L. | GC | S - Sale | $1.29 | -1,572 | 225,520 | -1% | -$2,028 | ||||||
2025-01-07 | OM | Outset Medical, Inc. | Ahmed Nabeel | CFO | S - Sale | $1.29 | -1,835 | 308,932 | -1% | -$2,367 | ||||||
| M | 2025-01-02 | SLNO | Soleno Therapeutics Inc | Yen Kristen | SEE REMARKS | S - Sale | $45.78 | -4,860 | 76,605 | -6% | -$222,484 | |||||
| M | 2025-01-02 | SLNO | Soleno Therapeutics Inc | Mackaness James H | CFO | S - Sale | $45.78 | -7,874 | 111,298 | -7% | -$360,460 | |||||
| M | 2025-01-02 | SLNO | Soleno Therapeutics Inc | Hirano Patricia C | SEE REMARKS | S - Sale | $45.78 | -3,030 | 105,902 | -3% | -$138,709 | |||||
| M | 2025-01-02 | SLNO | Soleno Therapeutics Inc | Anish Bhatnagar | CEO | S - Sale | $45.78 | -21,091 | 698,462 | -3% | -$965,516 | |||||
2025-01-02 | ZYXI | Zynex Inc | Moorhead Daniel J | CFO | S - Sale | $7.88 | -10,000 | 26,299 | -28% | -$78,800 | ||||||
| D | 2024-12-18 | GTHP | Guided Therapeutics Inc | Imhoff John E | Dir, 10% | P - Purchase | $0.00 | +1,615,385 | 8,727,444 | +23% | +$0 | |||||
| M | 2024-12-16 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $27.22 | -20,800 | 263,119 | -7% | -$566,221 | |||||
2024-12-11 | LIVN | Livanova Plc | Bianchi Francesco | Dir | S - Sale | $50.99 | -1,250 | 7,522 | -14% | -$63,738 | ||||||
| DM | 2024-12-10 | SMLR | Semler Scientific, Inc. | Murphy-Chutorian Douglas | CEO | S - Sale+OE | $60.65 | -100,000 | 155,313 | -39% | -$6,064,805 | |||||
2024-12-05 | ELMD | Electromed, Inc. | Summers Andrew | Dir | S - Sale | $28.15 | -37,404 | 456,456 | -8% | -$1,052,752 | ||||||
| M | 2024-12-02 | ELMD | Electromed, Inc. | Summers Andrew | Dir | S - Sale | $30.12 | -65,630 | 493,860 | -12% | -$1,976,606 | |||||
| D | 2024-12-02 | TMDX | Transmedics Group, Inc. | Khayal Tamer I | Chief Commercial Officer | S - Sale+OE | $86.40 | -1,084 | 20,843 | -5% | -$93,658 | |||||
2024-12-02 | ZYXI | Zynex Inc | Moorhead Daniel J | CFO | S - Sale | $8.08 | -10,000 | 35,190 | -22% | -$80,800 | ||||||
2024-11-26 | BLFS | Biolife Solutions Inc | Wichterman Troy | CFO | S - Sale | $27.20 | -581 | 122,766 | 0% | -$15,803 | ||||||
2024-11-26 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $27.20 | -523 | 283,919 | 0% | -$14,226 | ||||||
2024-11-26 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $27.20 | -349 | 107,407 | 0% | -$9,493 | ||||||
2024-11-26 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $27.20 | -216 | 60,484 | 0% | -$5,875 | ||||||
2024-11-26 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $27.20 | -252 | 156,973 | 0% | -$6,854 | ||||||
2024-11-20 | POCI | Precision Optics Corporation, Inc. | Anania Peter V. | Dir | S - Sale | $5.00 | -14,400 | 138,598 | -9% | -$72,000 | ||||||
2024-11-21 | VASO | Vaso Corp | Ma Jun | Chief Exec Officer, Pres | P - Purchase | $0.13 | +200,000 | 20,796,292 | +1% | +$26,000 | ||||||
| M | 2024-11-18 | ELMD | Electromed, Inc. | Skarvan Kathleen | Dir | S - Sale | $28.01 | -150,000 | 81,383 | -65% | -$4,201,350 | |||||
| DM | 2024-11-15 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale+OE | $20.70 | -42,604 | 284,442 | -13% | -$882,110 | |||||
2024-11-14 | ZYXI | Zynex Inc | Sandgaard Thomas | Pres, CEO, COB, 10% | S - Sale | $8.09 | -2,000 | 14,603,662 | 0% | -$16,180 | ||||||
2024-11-15 | OM | Outset Medical, Inc. | Trigg Leslie | Chair, CEO | S - Sale | $0.80 | -5,645 | 913,621 | -1% | -$4,516 | ||||||
2024-11-15 | OM | Outset Medical, Inc. | Nash Marc | SVP Operations, R, D | S - Sale | $0.80 | -1,375 | 238,022 | -1% | -$1,100 | ||||||
2024-11-15 | OM | Outset Medical, Inc. | Brottem John L. | GC | S - Sale | $0.80 | -3,203 | 227,092 | -1% | -$2,562 | ||||||
2024-11-15 | OM | Outset Medical, Inc. | Ahmed Nabeel | CFO | S - Sale | $0.80 | -4,221 | 310,767 | -1% | -$3,377 | ||||||
2024-11-18 | HYPR | Hyperfine, Inc. | Teisseyre Thomas | COO | S - Sale | $0.85 | -2,800 | 88,227 | -3% | -$2,380 | ||||||
| D | 2024-11-12 | QTI | Qt Imaging Holdings, Inc. | Greene James S | Dir | P - Purchase | $0.58 | +428,082 | 828,082 | +107% | +$250,000 | |||||
| D | 2024-11-12 | QTI | Qt Imaging Holdings, Inc. | Dickson Daniel H | Dir | P - Purchase | $0.58 | +85,616 | 85,616 | New | +$50,000 | |||||
| D | 2024-11-12 | QTI | Qt Imaging Holdings, Inc. | Katz Avi S | COB | P - Purchase | $0.58 | +3,142,122 | 3,329,192 | >999% | +$1,834,999 | |||||
| D | 2024-11-12 | QTI | Qt Imaging Holdings, Inc. | Dinu Raluca | CEO | P - Purchase | $0.00 | +470,890 | 657,959 | +252% | +$0 | |||||
| D | 2024-11-12 | QTI | Qt Imaging Holdings, Inc. | Weiner Zeev | Dir | P - Purchase | $0.58 | +85,616 | 85,616 | New | +$50,000 | |||||
| D | 2024-11-12 | QTI | Qt Imaging Holdings, Inc. | Taylor Ross | Dir | P - Purchase | $0.58 | +171,232 | 171,232 | New | +$99,999 | |||||
2024-11-12 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $26.34 | -91 | 107,756 | 0% | -$2,397 | ||||||
2024-11-12 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $26.34 | -66 | 157,225 | 0% | -$1,738 | ||||||
2024-11-12 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $26.34 | -123 | 317,046 | 0% | -$3,240 | ||||||
2024-11-12 | BLFS | Biolife Solutions Inc | Wichterman Troy | CFO | S - Sale | $26.19 | -147 | 123,347 | 0% | -$3,850 | ||||||
| M | 2024-11-07 | ZYXI | Zynex Inc | Sandgaard Thomas | Pres, CEO, COB, 10% | S - Sale | $8.93 | -10,000 | 14,605,662 | 0% | -$89,280 | |||||
| D | 2024-11-11 | TMDX | Transmedics Group, Inc. | Khayal Tamer I | Chief Commercial Officer | S - Sale+OE | $90.04 | -1,458 | 20,843 | -7% | -$131,278 | |||||
2024-11-08 | VANI | Vivani Medical, Inc. | Williams Gregg | Dir, 10% | P - Purchase | $1.26 | +3,968,253 | 18,373,169 | +28% | +$4,999,999 | ||||||
| D | 2024-11-07 | SMLR | Semler Scientific, Inc. | Murphy-Chutorian Douglas | CEO | S - Sale+OE | $37.93 | -50,000 | 100,313 | -33% | -$1,896,500 | |||||
2024-11-07 | SMLR | Semler Scientific, Inc. | Semler Eric | Dir | P - Purchase | $37.93 | +50,000 | 699,492 | +8% | +$1,896,500 | ||||||
| D | 2024-11-05 | TMDX | Transmedics Group, Inc. | Basile Edward M | Dir | S - Sale+OE | $83.55 | -6,750 | 732 | -90% | -$563,994 | |||||
| M | 2024-11-04 | ZYXI | Zynex Inc | Sandgaard Thomas | Pres, CEO, COB, 10% | S - Sale | $8.51 | -6,000 | 14,615,662 | 0% | -$51,080 | |||||
| D | 2024-11-01 | TMDX | Transmedics Group, Inc. | Khayal Tamer I | Chief Commercial Officer | S - Sale+OE | $82.64 | -1,083 | 20,843 | -5% | -$89,499 | |||||
2024-11-01 | ZYXI | Zynex Inc | Moorhead Daniel J | CFO | S - Sale | $8.59 | -10,000 | 44,878 | -18% | -$85,900 | ||||||
2024-10-30 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $23.15 | -203 | 60,700 | 0% | -$4,699 | ||||||
2024-10-30 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $23.15 | -311 | 107,847 | 0% | -$7,200 | ||||||
2024-10-30 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $23.15 | -277 | 157,291 | 0% | -$6,413 | ||||||
2024-10-30 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $23.15 | -547 | 317,169 | 0% | -$12,663 | ||||||
2024-10-30 | BLFS | Biolife Solutions Inc | Wichterman Troy | CFO | S - Sale | $23.15 | -894 | 123,494 | -1% | -$20,696 | ||||||
| M | 2024-10-30 | ZYXI | Zynex Inc | Sandgaard Thomas | Pres, CEO, COB, 10% | S - Sale | $8.79 | -6,000 | 14,621,350 | 0% | -$52,740 | |||||
2024-10-28 | NXL | Nexalin Technology, Inc. | Owens David | Chief Medical Officer | P - Purchase | $2.19 | +500 | 148,293 | 0% | +$1,095 | ||||||
| DM | 2024-10-15 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale+OE | $23.23 | -20,000 | 317,716 | -6% | -$464,500 | |||||
| D | 2024-10-15 | TMDX | Transmedics Group, Inc. | Hassanein Waleed H | Pres, CEO | S - Sale+OE | $132.71 | -8,625 | 531,002 | -2% | -$1,144,648 | |||||
| D | 2024-10-15 | CBLL | Ceribell, Inc. | Tpg Gp A, LLC | 10% | P - Purchase | $17.00 | +380,268 | 3,967,422 | +11% | +$6,464,556 | |||||
| D | 2024-10-15 | CBLL | Ceribell, Inc. | Tammenoms Bakker Juliet | Dir | P - Purchase | $17.00 | +237,234 | 2,481,728 | +11% | +$4,032,978 | |||||
| M | 2024-10-01 | VANI | Vivani Medical, Inc. | Dwyer Donald | Chief Business Officer | P - Purchase | $1.13 | +2,500 | 50,000 | +5% | +$2,835 | |||||
2024-10-01 | SLNO | Soleno Therapeutics Inc | Yen Kristen | SEE REMARKS | S - Sale | $49.43 | -3,108 | 81,465 | -4% | -$153,627 | ||||||
2024-10-01 | SLNO | Soleno Therapeutics Inc | Mackaness James H | CFO | S - Sale | $49.43 | -8,077 | 119,172 | -6% | -$399,241 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |